Key result
Female sex does not predict higher mortality, MAEs, or SCI after t-Branch device repair.
Why the study?
Females are at increased risk of mortality compared to males after complex endovascular aortic repair, prompting examination of sex-related outcomes with the t-Branch device.
Does female sex affect outcomes in patients managed with the t-Branch device for complex aortic aneurysms?
Cohort (n=542)
Yes
Does female sex affect outcomes in patients managed with the t-Branch device for complex aortic aneurysms?
Absolute Event Rate: 16.2% vs 10.8%
p-value: p=0.084
In patients undergoing complex endovascular aortic repair with the t-Branch device, sex is not an independent predictor of mortality, MAEs, or SCI, despite higher unadjusted MAE rates in females.
Females face higher 30-day mortality after t-Branch repair; leaves open whether sex-specific protocols or device modifications are needed.
Introduction: Females are at increased risk of mortality compared to males after complex endovascular aortic repair. This study aims to examine sex-related peri-operative and follow-up outcomes in patients managed with the t-Branch device. Methods: A two-center retrospective analysis of patients managed with the off-the-shelf t-Branch device (Cook Medical Inc., Bjaeverskov, Denmark) between 1 January 2014 and 30 September 2020 was performed. Primary outcomes were sex-comparative 30-day mortality, major adverse events (MAEs) and spinal cord ischemia (SCI). Results: A total of 542 patients were included; 28.0% were females. Urgent repair and type I–III thoracoabdominal aneurysms were more common among females (52.6% vs. 34%, p = 0.01, and 57.1% vs. 35.8%, p = 0.004). Technical success was similar (97.4% vs. 96.9%, p = 0.755), as well as early mortality (16.2% in females vs. 10.8% in males; p = 0.084). SCI rates were similar between groups (13.6% vs. 9.2% p = 0.183). MAEs were more common in females; 33.7% vs. 21.4% (p = 0.022). Multivariate analysis did not identify sex as an independent predictor of adverse events. The 12-month survival rate was 75.7% (SE 0.045) for females and 84.1% (SE 0.026) for males (log rank, p = 0.10). Conclusions: Sex was not detected as an independent factor of mortality, MAEs and SCI within patients managed with the t-Branch device. Feasibility was high in both groups. No significant difference was shown in survival during the 12-month follow-up.
No takes yet. Share an insight, caveat, or question.
Nana et al. (2023) conducted a cohort in Complex aortic aneurysms (n=542). Female sex vs. Male sex was evaluated on 30-day mortality (p=0.084). Female sex was not an independent predictor of mortality, MAEs, or SCI after t-Branch device repair, with similar 30-day mortality between females and males (16.2% vs 10.8%, p=0.084).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: